What medication should be given to a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication Management for Symptom Control

For patients requiring symptom management during critical illness or end-of-life care, initiate opioids as first-line agents for pain and dyspnea, with morphine 2 mg IV bolus every 15 minutes as needed for opioid-naïve patients, followed by continuous infusion if symptoms persist. 1

Pain and Dyspnea Management

Opioid Therapy (First-Line)

  • Start with morphine 2 mg IV bolus (or equianalgesic dose of hydromorphone or fentanyl) for opioid-naïve patients experiencing pain or respiratory distress 1
  • Titrate to effect with no specified dose limit, adjusting based on patient size, age, and organ dysfunction 1
  • Administer bolus doses every 15 minutes as needed for morphine/hydromorphone, or every 5 minutes for fentanyl 1
  • Follow bolus with continuous infusion if breakthrough symptoms occur 1

Dosing Adjustments for Patients on Opioid Infusions

  • Give bolus dose equal to 2× the hourly infusion rate for patients already receiving morphine or hydromorphone infusions who develop breakthrough pain or dyspnea 1
  • Double the infusion rate if patient requires two bolus doses within one hour 1
  • Continue stable opioid doses for patients already comfortable on existing regimens 1

Sedation Management (Second-Line)

Benzodiazepines

  • Use sedatives only after pain and dyspnea are controlled with opioids, though combinations may be used concurrently 1
  • Start with midazolam 2 mg IV bolus followed by 1 mg/hour infusion for benzodiazepine-naïve patients with agitation 1
  • Administer bolus doses every 5 minutes as needed, using 1-2× the hourly infusion rate for breakthrough agitation 1
  • Double infusion rate if two boluses required within one hour 1

Alternative Sedatives

  • Consider propofol or barbiturates as second-line when benzodiazepines are ineffective or in exceptional circumstances 1
  • Propofol is appropriate for patients already stable on propofol infusions or when providers are experienced with its use 1

Gastrointestinal Symptom Management

Nausea and Vomiting

  • Administer ondansetron 8 mg IV every 8 hours scheduled 30 minutes prior to each dose of therapy 1
  • Add prochlorperazine 10 mg IV every 6 hours PRN or lorazepam 0.5 mg IV every 6 hours PRN for breakthrough symptoms 1

Diarrhea

  • Give loperamide 2 mg every 2 hours as needed after ruling out gastrointestinal infection 1
  • Escalate to diphenoxylate/atropine two tablets PO every 6 hours PRN for loperamide-refractory diarrhea 1

Gastrointestinal Prophylaxis

  • Prescribe pantoprazole 40 mg PO/IV daily or famotidine 20 mg PO/IV twice daily 1
  • Avoid steroids for prevention of gastrointestinal symptoms 1

Respiratory Symptom Management

Post-Extubation Stridor

  • Use inhaled epinephrine to treat post-extubation stridor in conscious patients 1

Supplemental Oxygen

  • Provide supplemental oxygen only for comfort, not routinely 1

Additional Supportive Medications

Antiemetics

  • Order antinauseant medications PRN with all opioid prescriptions 1

Dermatologic Symptoms

  • Give diphenhydramine 25 mg PO every 6 hours PRN or hydroxyzine 10 mg PO every 6 hours PRN for pruritus 1
  • Apply Aveeno or Lubriderm lotion three times daily for skin symptoms 1

Cardiovascular Support

  • Administer NS or LR 500 mL IV fluid bolus for hypotension 1
  • Replete electrolytes and monitor for arrhythmias continuously 1

Critical Pitfalls to Avoid

  • Never use mixed agonist-antagonist opioids (such as nalbuphine or butorphanol) as they may precipitate withdrawal 1
  • Do not routinely use anticholinergics, furosemide, or methylprednisolone prophylactically without specific indications 1
  • Avoid neuromuscular blocking agents during symptom management; allow effects to wear off prior to withdrawal of life-sustaining measures 1
  • Do not prescribe NSAIDs in heart failure patients without specific compelling indications, as they are generally contraindicated 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the potential risks and considerations for a 63-year-old male taking multiple medications when a new medication is added to his regimen?
What is an appropriate adjunct therapy for an elderly patient with complex conditions on multiple medications?
A patient with multiple comorbidities is taking Milk of Magnesia Concentrate Suspension, Atorvastatin Calcium (Lipitor) Oral Tablet, Amlodipine Besylate (Norvasc) Oral Tablet, Ezetimibe (Zetia) Tablet, DULoxetine (Cymbalta) HCl Capsule, Ondansetron (Zofran) HCl Oral Tablet, Metoprolol Succinate (Lopressor) ER Tablet, Roxicodone (Oxycodone) Oral Tablet, Calcitriol Oral Capsule, Omeprazole (Prilosec) Capsule, Acetaminophen (Tylenol) Tablet, SUMAtriptan (Imitrex) Succinate Oral Tablet, Sennosides Tablet, Lac-Hydrin (AmLactin) Five External Lotion, ZyrTEC (Cetirizine) Allergy Oral Tablet, HydrALAZINE (Apresoline) HCl Tablet, Glucagon Emergency Kit, Aspirin Oral Tablet, Melatonin Tablet, Multiple Vitamins-Minerals Tablet, Bumetanide (Bumex) Tablet, Lidocaine (Xylocaine) External Patch, Insulin Glargine (Lantus) Subcutaneous Solution, Phentermine (Adipex) HCl Oral Capsule, NovoLOG (Aspart) FlexPen Subcutaneous Solution, and Cholecalciferol (Vitamin D3) Tablet, with lab results including a thyroid panel, Complete Blood Count (CBC), basic metabolic panel, lipid profile, T4 free, Thyroid-Stimulating Hormone (TSH), B12, hemoglobin A1C, Vitamin D 25-hydroxy, and 1,25-dihydroxy. What adjustments should be made to the patient's medication regimen?
Can a patient create their own drug cards?
What are the 200 most common medications?
What medication should be started for an elderly patient with a history of hypertension, presenting with symptoms of dementia, including forgetting recent events, misplacing items, and social withdrawal, with a low mini-mental state examination (MMSE) score and cortical atrophy on magnetic resonance imaging (MRI)?
What is the recommended treatment for a patient with a Klebsiella pneumoniae urinary tract infection (UTI)?
Is it reasonable to start Micafungin (Micafungin) in a patient with persistent fever and potential fungal infection?
Why is Dual Antiplatelet Therapy (DAPT) with aspirin and a P2Y12 inhibitor recommended for patients with minor stroke or high-risk Transient Ischemic Attack (TIA), while Single Antiplatelet Therapy (SAPT) with aspirin is used for lower-risk TIA patients?
What is the recommended treatment regimen for a low-risk patient with community-acquired pneumonia (CAP)?
What causes a discrepancy between a positive in-office rapid flu test for both Influenza A (Flu A) and Influenza B (Flu B) and a negative Polymerase Chain Reaction (PCR) test in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.